Baystate Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Baystate Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$4.83K	Hold	147	–	–	﹤0.01%	896
2023 Q3	$4.1K	Hold	147	–	–	﹤0.01%	704
2023 Q2	$5.02K	Hold	147	–	–	﹤0.01%	702
2023 Q1	$4.43K	Buy	147 +100	+213%	+$3.1K	﹤0.01%	709
2022 Q4	$1K	Hold	47	–	–	﹤0.01%	830
2022 Q3	$2K	Hold	47	–	–	﹤0.01%	729
2022 Q2	$1K	Hold	47	–	–	﹤0.01%	809
2022 Q1	$2K	Sell	47 -385	-89%	-$18.4K	﹤0.01%	738
2021 Q4	$26K	Hold	432	–	–	﹤0.01%	424
2021 Q3	$32K	Buy	432 +57	+15%	+$4.78K	﹤0.01%	345
2021 Q2	$35K	Hold	375	–	–	﹤0.01%	316
2021 Q1	$33K	Buy	375 +60	+19%	+$5.95K	﹤0.01%	302
2020 Q4	$29K	Buy	+315	New	+$25.1K	﹤0.01%	307
2020 Q3	–	Sell	-185	Closed	-$10K	–	640
2020 Q2	$10K	Buy	+185	New	+$7.93K	﹤0.01%	385

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Baystate Wealth Management's ARKG Position: Q4 2023 in Review

Baystate Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2023 at 147 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Baystate Wealth Management first reported a position in ARKG in Q2 2020 and has held it in 14 quarters since. The position peaked at $35K in Q2 2021. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

Baystate Wealth Management held 147 shares of ARK Genomic Revolution ETF worth $4.83K as of Q4 2023.
Baystate Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q4 2023.
ARK Genomic Revolution ETF made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #896 holding.
Baystate Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 14 quarters since.
Baystate Wealth Management's ARK Genomic Revolution ETF position peaked at $35K in Q2 2021.
298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.